caffeine has been researched along with vasobral in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Migeon, P; Poncin-Lafitte, M; Rancurel, G; Rapin, JR | 1 |
Burdukovskaia, NL; Molokov, DD; Shprakh, VV; Tatarinova, MB | 1 |
Sadekov, RA | 1 |
Grinshteĭn, AB; Kromm, OK; Pavlovskaia, MV; Shnaĭder, NA | 1 |
Zaĭtseva, IN | 1 |
Azimova, IuE; Tabeeva, GR | 1 |
Kamchatnov, PR | 2 |
Barantsevich, ER; Belskaya, GN; Kopishinskaya, SV; Levin, OS; Lukashevich, IG; Ostroumova, OD; Psokhina, OV; Radiuk, MA; Vasenina, EE | 1 |
2 trial(s) available for caffeine and vasobral
Article | Year |
---|---|
[The use of vasobral in patients with chronic cerebrovascular disorders].
Topics: Adult; Aged; Caffeine; Cerebrovascular Disorders; Chronic Disease; Dihydroergotoxine; Drug Combinations; Female; Humans; Male; Middle Aged; Treatment Outcome | 2011 |
[Efficacy of the combination drug vasobral in chronic vascular encephalopathy].
Topics: Adult; Aged; Brain Damage, Chronic; Brain Ischemia; Caffeine; Cerebral Small Vessel Diseases; Dihydroergotoxine; Drug Combinations; Female; Humans; Male; Middle Aged; Treatment Outcome | 2014 |
7 other study(ies) available for caffeine and vasobral
Article | Year |
---|---|
[Vasobral and stabilized cerebral vascular complication: hemodynamic and psychometric study].
Topics: Aged; Brain Ischemia; Caffeine; Cerebrovascular Circulation; Dihydroergotoxine; Drug Combinations; Humans; Middle Aged; Psychometrics | 1987 |
[Vasobral in the treatment of initial atherosclerotic circulatory encephalopathy].
Topics: Adult; Aged; Caffeine; Dihydroergotoxine; Drug Combinations; Drug Evaluation; Female; Humans; Intracranial Arteriosclerosis; Male; Middle Aged | 1996 |
[The influence of alpha-dihydroergocryptine derivatives on psychomotor manifestations in Parkinson disease].
Topics: Antiparkinson Agents; Caffeine; Dihydroergotoxine; Drug Combinations; Female; Humans; Male; Memory; Middle Aged; Parkinson Disease; Psychomotor Performance; Treatment Outcome | 2000 |
[Experience in the administration of vasobral in sensorineural vascular hypoasusis].
Topics: Administration, Oral; Adult; Caffeine; Dihydroergotoxine; Drug Administration Schedule; Drug Combinations; Hearing Loss, Sensorineural; Humans; Neuroprotective Agents; Osteochondritis; Retrospective Studies; Vertebrobasilar Insufficiency | 2001 |
[Use of vasobral in therapy of central nervous system pathology in children of early age].
Topics: Administration, Oral; Caffeine; Central Nervous System Diseases; Child, Preschool; Dihydroergotoxine; Dose-Response Relationship, Drug; Drug Combinations; Follow-Up Studies; Humans; Infant; Psychomotor Performance; Treatment Outcome | 2010 |
[Preventive treatment of migraine with vasobral: a multicenter trial].
Topics: Adolescent; Adult; Aged; Caffeine; Dihydroergotoxine; Drug Combinations; Female; Humans; Male; Middle Aged; Migraine Disorders; Prospective Studies; Treatment Outcome; Young Adult | 2010 |
[Vasobral in the treatment of brain lesions: views of physicians and patients].
Topics: Caffeine; Cerebrovascular Disorders; Cognition; Cognition Disorders; Dihydroergotoxine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Memory; Patients; Physicians; Surveys and Questionnaires; Vertigo | 2013 |